Spleen Lesion
A spleen lesion is any abnormal area within the spleen identified on imaging. It is a general descriptive term rather than a specific diagnosis and can represent a wide range of conditions, from common benign findings such as cysts and hemangiomas to inflammatory lesions, infections, infarcts, lymphoma, or metastases. Many spleen lesions are small, benign, and discovered incidentally on imaging done for other reasons. Careful characterization with ultrasound, CT, and MRI—along with the clinical context—is central to determining whether reassurance, follow-up, or further evaluation is needed.
What is it?
The spleen is an organ in the upper left abdomen that filters blood, supports immune function, and plays roles in the body’s response to certain infections. A spleen lesion is any focal abnormal area seen within the spleen on imaging. It is a general descriptive term rather than a specific diagnosis. Spleen lesions vary widely in their cause, appearance, and clinical significance—ranging from small, incidental, benign findings that require no treatment to important markers of infection, inflammation, or cancer that need targeted evaluation.
Spleen lesions can be broadly grouped by type. Benign lesions are the most common in patients without known cancer or infection. Splenic cysts (both true cysts and post-traumatic or post-inflammatory pseudocysts) are among the most frequent findings and typically appear as fluid-filled lesions with smooth walls. Splenic hemangiomas—benign masses of abnormal blood vessels—are the most common benign solid lesions and often have characteristic imaging features. Splenic lymphangiomas (benign lymphatic malformations) and hamartomas (benign disorganized collections of normal splenic tissue) are less common but well-recognized benign lesions. Small splenic granulomas—often calcified areas from prior exposure to infections such as tuberculosis or histoplasmosis—are a very common finding, particularly in patients from or living in specific regions.
Inflammatory and infectious lesions include splenic abscesses (localized collections of pus, often from bacteremia, infective endocarditis, or immunosuppression), fungal microabscesses (particularly in immunocompromised patients), tuberculosis and other granulomatous infections, and parasitic lesions such as hydatid (echinococcal) cysts. Splenic infarcts—areas of tissue death from interrupted blood supply—can appear as focal lesions, often wedge-shaped and pointing toward the splenic hilum, in patients with atrial fibrillation, endocarditis, sickle cell disease, or clotting disorders.
Malignant lesions include splenic involvement by lymphoma (which is one of the more common causes of solid splenic lesions in adults, particularly when multiple lesions are present or when systemic symptoms accompany the finding), metastases from cancers of the breast, lung, gastrointestinal tract, ovary, melanoma, and other primary sites, and—much less commonly—primary splenic angiosarcoma and other rare primary tumors. Splenic involvement by leukemia and other hematologic conditions can also produce lesions or diffuse changes.
The clinical significance of a spleen lesion depends heavily on its imaging features, size, number, and the patient’s overall clinical context. A small, well-defined, characteristic-appearing benign lesion in an otherwise healthy patient often requires only reassurance, while a new, multiple, or atypical lesion in a patient with known cancer, immunosuppression, systemic symptoms, or recent illness may require prompt further evaluation. Many patients with spleen lesions have no symptoms attributable to the lesion itself, and the finding is discovered incidentally on imaging done for other reasons.
Symptoms, when they occur, depend on the underlying cause. Possible features include upper left abdominal pain or fullness, early fullness with meals, pain that may radiate to the left shoulder, fatigue, unexplained weight loss, night sweats, fevers, easy bruising or bleeding from low platelets, frequent infections from low white blood cell counts, or symptoms attributable to a primary cancer or infection. Some patients present with acute symptoms suggesting complications such as bleeding, rupture, or infection.
Evaluation combines careful history, physical examination, blood tests, and imaging. Blood tests may include a complete blood count, peripheral blood smear, inflammatory markers (CRP and ESR), liver function tests, blood cultures (when infection is suspected), viral hepatitis testing, HIV testing, autoimmune markers, tumor markers, and specialized studies based on the clinical picture. Ultrasound is often the first imaging tool and can identify many lesions and characterize simple cysts. CT with contrast provides detailed information about size, number, location, enhancement patterns, and relationship to surrounding structures, and is particularly useful for assessing lymph nodes and other abdominal organs. MRI with contrast offers excellent characterization of certain lesions—including hemangiomas and complex cystic lesions—and is helpful when imaging features are atypical on other studies. PET/CT is used in selected patients, particularly for staging lymphomas or evaluating suspected metastatic disease. Image-guided biopsy of the spleen is performed in carefully selected cases when noninvasive testing cannot establish the diagnosis, because the spleen is highly vascular and biopsy carries some risk of bleeding.
Important to Know
Because “spleen lesion” is a broad descriptive term, management depends heavily on identifying the specific type of lesion and the underlying cause. Careful characterization on imaging—often with more than one modality—is the first step. In many patients, the imaging features and clinical context are enough to establish a confident diagnosis without additional testing.
For small, characteristic benign lesions—such as simple cysts, typical hemangiomas, and small calcified granulomas—no specific treatment is usually needed. Reassurance and clear documentation of the finding in the medical record are typically sufficient, and many such lesions do not require any specific follow-up. Larger or less typical lesions may be monitored with periodic imaging for a defined time to confirm stability, with the frequency and duration individualized to the specific findings.
For inflammatory and infectious lesions, treatment is directed at the underlying condition. Splenic abscesses typically require antibiotics and, in many patients, image-guided drainage, with surgery reserved for complicated cases. Fungal microabscesses in immunocompromised patients are treated with antifungal therapy and management of the underlying immunosuppression. Tuberculosis and other granulomatous infections are treated with disease-specific regimens. Parasitic lesions such as hydatid cysts require specific antiparasitic medications and often surgical or interventional treatment. Splenic infarcts are usually managed supportively, with treatment focused on identifying and addressing the underlying cause (such as anticoagulation for atrial fibrillation or treatment of infective endocarditis).
For lesions that are new, multiple, atypical, or accompanied by concerning features such as systemic symptoms, low blood counts, enlarged lymph nodes, or a known history of cancer, prompt further evaluation is important. This may include additional imaging (such as PET/CT), tissue diagnosis (often from an accessible lymph node, bone marrow, or another site), and consultation with hematology, oncology, or infectious disease depending on the suspected diagnosis. Splenectomy or partial splenectomy is considered in selected patients, both for diagnosis (when other approaches have not established the diagnosis) and for treatment (in specific conditions such as some primary splenic lymphomas or complicated lesions).
Patients undergoing total or partial splenectomy require specific attention to infection prevention. This includes vaccinations against encapsulated bacteria (such as pneumococcal, meningococcal, and Haemophilus influenzae type b vaccines), antibiotic prophylaxis in selected patients, education about prompt evaluation of fevers, and consideration of travel-related risks.
Care is typically coordinated by primary care clinicians and, when relevant, radiologists, hematologists, oncologists, infectious disease specialists, hepatobiliary or general surgeons, and interventional radiologists. Imaging and laboratory findings are interpreted alongside the patient’s symptoms, examination, and broader clinical context rather than in isolation.
Patient education plays an important role. Understanding that spleen lesions have many possible causes—most of which are benign—can reduce anxiety while allowing for appropriate evaluation of specific findings that need attention. Clear communication about the plan of care, the rationale for any recommended follow-up, and the signs that warrant urgent evaluation contribute to better outcomes.
Red flag symptoms include sudden severe upper left abdominal pain (especially after trauma to the abdomen), lightheadedness or fainting, rapid heart rate, cool clammy skin or signs of shock, high fever with chills, severe shortness of breath, easy bruising or bleeding with severe symptoms, severe fatigue with confusion, significant unintentional weight loss with night sweats, or rapid worsening of overall condition. These warrant prompt or urgent medical evaluation, as they may indicate splenic rupture, severe infection, hematologic complications, or other serious conditions.